25 studies recruiting now13 research sites across CanadaJoin the community
Home/Conditions/Eczema & Atopic Dermatitis
Medical condition

Eczema & Atopic Dermatitis

Plain-language information about eczema and atopic dermatitis in Canada, and the research enrolling for them now.
Plain-language guide, not medical advice
Reading time4 min
In Canada15% of children, 4% of adults
Studies recruiting6 now enrolling

Eczema is a group of conditions that leave the skin dry, itchy and inflamed. The most common form is atopic dermatitis, in which the skin barrier does not hold moisture well and the immune system overreacts to ordinary triggers. It usually starts in childhood and often eases with age, but it can begin or carry on in adulthood, and it comes and goes in flares.

By the numbers in Canada
15%of children in Canada, and 4% of adults, are affected by atopic dermatitis, the most common form of eczema, according to the Eczema Society of Canada, which describes the majority of cases as mild to moderate.
Source: Eczema Society of Canada, About Eczema, 2026
  • In the Eczema Society of Canada 2025 survey of 389 Canadian adults with eczema, 65% reported an impact on overall quality of life and 54% an impact on mental health. Forty-four percent said health care providers rarely or never ask about quality of life, while 83% said they want providers to ask. Source: Eczema Society of Canada, The Burden of Eczema in Canada 2025 Survey Report, 2025
  • In the same survey, 25% of respondents reported a financial burden from treatment costs, rising to 32% among those with severe eczema. Thirteen percent had delayed a prescription treatment because of cost, rising to 26% among those with severe eczema, and financial burden was reported by 39% of respondents who identified as BIPOC compared with 21% of White respondents. Source: Eczema Society of Canada, The Burden of Eczema in Canada 2025 Survey Report, 2025
  • An Ontario study covering 2005 to 2015 identified atopic dermatitis in 3.1% of a primary care sample of 249,984 patients, and found emergency department visits and hospitalizations uncommon, at 1.2 events for every 100 patients with atopic dermatitis over the study period. Source: CMAJ Open, atopic dermatitis in Ontario, 2022
Worldwide129 million people worldwide were living with atopic dermatitis in the Global Burden of Disease Study 2021, up from 107 million in 1990, an age-standardised prevalence of 1,728.5 per 100,000, with 148 million cases projected by 2050.Source: Institute for Health Metrics and Evaluation, GBD 2021 analysis published in The Lancet Respiratory Medicine, 2025

What eczema is, and what it is not

It is not a hygiene problem, and it is not contagious. The skin barrier itself behaves differently, which is why moisturising and bathing routines are part of care rather than an afterthought. It is also not usually caused by one food or one product: triggers vary from person to person, and for most people no single culprit is ever found.

The itch is not a minor detail either. It is often the hardest part, it disrupts sleep, and it can continue even when the visible skin looks better. Eczema also does not look the same on every skin tone: the Canadian Dermatology Association notes that on darker skin it often appears ashen, brown or grey rather than red, which can make it harder to recognise.

Signs and symptoms

  • Intense itching, which is often the most difficult symptom
  • Dry, scaly or rough patches of skin
  • Redness on lighter skin, or ashen, brown, grey or purple tones on darker skin
  • Skin that weeps, crusts, or becomes thickened and leathery over time
  • Cracking, especially on the hands, behind the knees and inside the elbows
  • Broken sleep caused by night-time itching
  • Skin infections, which can follow scratching

Severity ranges widely. The Eczema Society of Canada describes the majority of Canadian cases as mild to moderate, and the same person can have long settled stretches between flares.

An adult applying moisturiser to the skin of the upper arm.
Eczema is diagnosed clinically in Canada, from the pattern and appearance of the rash and a history of itch and allergic conditions. Illustrative photograph.

What raises the risk

Some things cannot be changed:

  • A personal or family history of eczema, asthma, hay fever or food allergy
  • Genetic differences affecting the skin barrier
  • Age at onset, since most cases begin in early childhood
  • Climate and environment, including cold, dry Canadian winters

Others can often be worked on, usually with support from a health care team:

  • Contact with fragranced products, harsh soaps and detergents
  • Dust, animal dander, smoke and other triggers you have identified
  • Skin dryness from infrequent moisturising, long hot showers, and scratching

How eczema is diagnosed in Canada

Eczema is diagnosed clinically. A family doctor, nurse practitioner, paediatrician or dermatologist looks at the pattern, location and appearance of the rash, and asks about itch, family history of allergic conditions, and what makes it worse. No blood test confirms atopic dermatitis, although testing is sometimes used when allergy or another diagnosis is being considered. The Canadian Dermatology Association notes that patch testing is used specifically when allergic contact dermatitis is suspected.

Treatment and day-to-day management

Clinical research for Eczema & Atopic Dermatitis is enrolling. See the current studies

Care in Canada usually combines daily skin care with something to settle inflammation during a flare, plus attention to itch and sleep. Depending on your situation and what matters to you, a health care team may discuss:

  • Daily skin care with moisturisers and bathing routines to support the skin barrier
  • Topical anti-inflammatory treatments, including topical corticosteroids and non-steroidal options such as calcineurin inhibitors, PDE4 inhibitors and topical JAK inhibitors
  • Phototherapy delivered in clinic settings
  • Systemic treatments for moderate to severe disease, including biologics that target type 2 inflammation and oral JAK inhibitors
  • Identifying and avoiding triggers, managing itch and sleep, and treating skin infection when it occurs

Cost can shape what is realistic. In the Eczema Society of Canada 2025 survey, 25% of respondents reported a financial burden from treatment costs and 13% had delayed a prescription treatment because of cost, rising to 26% among those with severe eczema. Coverage differs by province, territory and private plan. What suits one person will not suit another, and which of these applies to you is a decision for you and your own clinician. This page is not a recommendation about any of them.

When to talk to a doctor

  • See a clinician if itching disrupts sleep, school or work, if a rash keeps coming back, or if moisturisers and over-the-counter products are not enough.
  • Book an appointment promptly for signs of skin infection, including yellow crusting, weeping, pus, increasing pain, spreading redness or fever.
  • Seek urgent care for widespread painful blistering, for a rapidly worsening rash with fever and feeling unwell, or for eczema with a cluster of small punched-out sores, which needs immediate assessment.

Why clinical research matters for eczema

Researchers are still working out why the skin barrier and immune system behave differently in some people, why itch persists even when visible skin improves, and how to predict who will respond to which treatment. Canada also has no current national prevalence data: the figures above come from a national organisation, from one province\’s primary care records, and from a survey of 389 self-selected respondents, 77% of whom identified as BIPOC, so none of them is a representative national measurement. That survey also found that 44% of respondents said health care providers rarely or never ask about quality of life, while 83% want to be asked. Studies now recruiting include newer biologics and targeted oral medicines, non-steroidal topicals, treatments aimed specifically at itch, prevention studies in infants at high risk, and work on recognising and assessing eczema across the full range of skin tones.

Clinical studies are how those questions get answered. Taking part is voluntary, you give informed consent before anything begins, and you can stop at any time without affecting the care you get from your own doctor. Joining a study does not mean giving up your current treatment, and no one can tell in advance whether a study will help you personally.

Learn more from Canadian sources

Where this information comes from (5 sources)
  1. Eczema Society of Canada, About Eczema, 2026
  2. Eczema Society of Canada, The Burden of Eczema in Canada 2025 Survey Report, 2025
  3. Canadian Dermatology Association, Eczema, 2026
  4. CMAJ Open, Sociodemographic characteristics and emergency department visits and inpatient hospitalizations for atopic dermatitis in Ontario, 2022
  5. Institute for Health Metrics and Evaluation, GBD 2021 burden of asthma and atopic dermatitis, published in The Lancet Respiratory Medicine, 2025

This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.

Common questions

How common is eczema in Canada?

The Eczema Society of Canada estimates that atopic dermatitis affects 15% of children and 4% of adults in Canada. An Ontario study covering 2005 to 2015 identified atopic dermatitis in 3.1% of a primary care sample of 249,984 patients. Neither figure comes from national health surveillance, so they should be read as an organisational estimate and a single-province measurement.

Does eczema look the same on all skin tones?

No. The Canadian Dermatology Association notes that on darker skin tones eczema often appears ashen, brown or grey rather than red, which can make it harder to recognise. The Eczema Society of Canada 2025 survey also found that BIPOC respondents reported financial burden from treatment at 39% compared with 21% among White respondents.

Is cost a barrier to eczema treatment in Canada?

The Eczema Society of Canada 2025 survey found that 25% of respondents reported a financial burden from treatment costs and 13% had delayed a prescription treatment because of cost. Among those with severe eczema, 26% had delayed treatment for that reason. Coverage varies by province, territory and private plan.

What to do next
  1. Talk to your doctor. This guide is information, not medical advice.
  2. See the current studies. 6 studies for Eczema & Atopic Dermatitis
  3. Not ready yet? Join the community and we will write to you when something opens.
Research studies

Studies for Eczema & Atopic Dermatitis

See all Eczema & Atopic Dermatitis trials →

Learn more about Eczema & Atopic Dermatitis

Health blog →

Connecting Canadians with clinical research studies conducted by a network of physicians committed to advancing medicine — since 1995.

JoinAStudy.ca provides information about clinical research and does not provide medical advice, diagnosis, or treatment. Only a qualified study doctor can determine your eligibility for a study. Participation is always voluntary.

© 2026 JoinAStudy.ca · A network of Canadian physicians.|Designed by Pixelore.ca